Accès ouvert
2025
article
OpenAlex
Li-Ling Luo, Chao Jiang, Songxi Xie
BACKGROUND: Previous studies showed that high mobility group box-1 (HMGB1) facilitates the initiation and progression of esophageal squamous cell carcinoma (ESCC), and the current research investigated the detailed mechanisms implicated. METHODS: The impact of HMGB1 and IGFBP3 levels on the survival of …
cn
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Shujie Huang, Hongfan Yu, Zijie Li, Yong Tang et autres
Background: Radiation-associated adverse events (ADEs) in patients with esophageal squamous cell carcinoma (ESCC) remain a problem. Recent research has focused on reducing radiation-associated ADEs while maintaining efficacy, particularly through the combination of immune checkpoint inhibitors (ICIs) with chemotherapy. Patient-reported outcomes (PROs) have …
cn
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Shujie Huang, Hansheng Wu, Chao Cheng, Ming Zhou et autres
Purpose: The present study sets out to evaluate the feasibility, safety, and effectiveness of conversion surgery following induction immunochemotherapy for patients with initially unresectable locally advanced esophageal squamous cell carcinoma (ESCC) in a real-world scenario. Materials and Methods: In this multi-center, real-world …
cn
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Yi Pan, Peixin Tan, Songxi Xie, Jiewen Chen et autres
Contrast-enhanced computed tomography revealed sclerotic enhancement of the T1 vertebral body and the vertebral bodies from C2 to T2.
cn
(code pays fourni par la source)
Accès ouvert
2020
preprint
OpenAlex
Yi Pan, Xue‐Ning Yang, Zhiyong Chen, Liang Yu et autres
Abstract Background Preoperative concurrent chemoradiotherapy (CCRT) followed by surgery has become the standard treatment for potentially resectable superior sulcus (SS) tumours. To date, intraoperative radiotherapy (IORT) for SS tumour treatment is primarily performed via brachytherapy; it achieves high local control, but has …
us, cn
(code pays fourni par la source)
2010
other
OpenAlex
Songxi Xie, Weixiong Li, Yujuan Huang, Jiang-guang Chen et autres
OBJECTIVE: To establish a diagnostic model of protein fingerprint pattern in the cerebrospinal fluid (CSF) for non-small-cell lung cancer (NSCLC) patients with brain metastases. METHODS: The CSF samples were obtained from 29 NSCLC patients with brain metastasis, 23 non-tumor patients and 10 …
cn
(code pays fourni par la source)
Accès ouvert
2007
article
OpenAlex
Yujuan Huang, Yi-Long Lung Cancer Wu, Songxi Xie, Jingji Yang et autres
BACKGROUND: Conventional treatment for non-small cell lung cancer (NSCLC) brain metastases (BM) is whole-brain radiotherapy (WBRT). The efficacy is limited. It might be increased by a potent radiosensitizer such as gemcitabine, which is believed to cross the disrupted blood-brain barrier. The primary …
cn
(code pays fourni par la source)